통증 관리 기기 시장 규모, 점유율, 예측 및 동향 분석 : 제품, 통증 유형, 유통 및 최종 사용자별 - 세계 예측(-2031년)

Pain Management Devices Market Size, Share, Forecast, & Trends Analysis by Product (Neurostimulation [DBS, TENS, VNS], Infusion Pump, Compression), Pain Type (Surgical, Musculoskeletal, Neuropathic, Cancer), Distribution, End User-Global Forecast to 2031

The global pain management devices market is projected to reach $16.40 billion by 2031 at a CAGR of 5.3% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the pain management devices market is driven by the increasing cases of chronic conditions associated with the geriatric population, increasing number of surgical procedures, increasing prevalence of cancer & musculoskeletal diseases, technological advancements in pain management devices, and increasing healthcare expenditures. However, the high costs of pain management devices & therapies and product recalls restrain the growth of this market.

Furthermore, partnerships & collaborations by pain management device companies, integration of digital health technologies into pain management devices, and emerging economies are expected to generate growth opportunities for the players operating in this market. However, lack of awareness regarding the use of pain management devices in developing countries and the use of alternative technologies are major challenges impacting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global pain management devices market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Boston Scientific Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.), Baxter International, Inc. (U.S.), VirpaxPharmaceuticals, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Rusan Pharma Ltd (India), Grunenthal GmbH (Germany), OMRON Healthcare, Inc. (U.S.), and Nevro Corp. (U.S.).

Among all the products studied in this report, the compression therapy devices segment is expected to account for the largest share of over 28.1% of the pain management devices market. The large market share of this segment is attributed to the increasing number of orthopedic procedures and the rising global geriatric population, which is highly susceptible to improper blood flow, edema, and vein problems such as varicose veins, spider veins, and leg ulcers.

Among all the portabilities studied in this report, in 2024, the wearable & implantable segment is expected to account for the largest share of the pain management devices market. The segment's large market share is attributed to the flexibility and comfort of wearable & implantable pain management devices. These devices have a high individual preference due to their portability, affordability, and the ability to reduce pain in the short term and improve physical activity.

Among all the pain types studied in this report, in 2024, the chronic pain segment is expected to account for the largest share of the pain management devices market. The segment's large market share is attributed to the high number of accidents, increasing youth participation in sports and athletics, the consequent rise in the incidence of sports injuries, and the rising geriatric population at risk of developing osteoarthritis.

Among all the distribution channels studied in this report, in 2024, the retail pharmacies segment is expected to account for the largest share of the pain management devices market. The large market share of this segment is attributed to the availability of a diverse selection of pain management devices, such as compression therapy devices, including bandages, garments, and intermittent/sequential pneumatic compression pumps at retail pharmacies, which enables patients to select the best pain management options depending on their specific preferences, needs, and healthcare expert recommendations.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the pain management devices market. The large market share of this segment can be attributed to advancements in pain management devices, the increased adoption of pain management devices by hospitals & clinics, a large number of patient visits in hospitals & clinics for pain management & surgical procedures, and the rising geriatric population requiring pain management products.

An in-depth analysis of the geographical scenario of the global pain management devices market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 30.7% of pain management devices market. In the region, in 2024, the U.S. is expected to account for the largest share of the pain management devices market in North America. The large share of the regional market is attributed to the presence of major pain management device manufacturers, advanced healthcare infrastructure, increasing healthcare expenditure, the increasing prevalence of cancer & musculoskeletal diseases, and the rising number of surgical procedures in the region.

Scope of the Report:

Pain Management Devices Market Assessment-by Product

• Compression Therapy Devices
  • Bandages
  • Garments
• Stockings
• Socks & Sleeves
• Wraps & Tapes
• Other Garments
  • Intermittent/Sequential Pneumatic Compression Pumps
  • Other Pressure Pumps
• Neurostimulation Devices
  • Deep Brain Stimulation (DBS) Systems
  • Spinal Cord Stimulation Systems
  • Transcutaneous Electrical Nerve Stimulation (TENS) Systems
  • Vagus Nerve Stimulation (VNS) Systems
  • Other Neurostimulation Devices
• Analgesic Infusion Pumps
  • Intrathecal Infusion Pumps
  • External Infusion Pumps
• Electrotherapy Devices
• Ablation Devices
• Accessories

Note: Other Pressure Pumps include calibrated, non-calibrated, and portable pressure pumps.

Note: Other Neurostimulation Devices include Responsive Neurostimulation Systems (RNS), Sacral Nerve Stimulation (SNS) Systems, and syringe devices.

Note: Other Garments include inflatable devices, liners, bands, belts, braces, and tubes.

Pain Management Devices Market Assessment-by Portability

• Stationary/Benchtop
• Wearable & Implantable

Pain Management Devices Market Assessment-by Pain Type

• Acute Pain
  • Injuries
  • Surgeries
• Chronic Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Other Chronic Pain Types

Note: Other Chronic Pain Types include nociceptive pain, migraine, and carpal tunnel syndrome.

Pain Management Devices Market Assessment-by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online/E-commerce Platforms

Pain Management Devices Market Assessment-by End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Physiotherapy Centers
• Home Care Settings
• Other End Users

Note: Other End Users include rehabilitation centers and sports medicine centers

Pain Management Devices Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Switzerland
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Data Collection & Validation Process
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing & Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Increasing Cases of Chronic Conditions Associated with the Geriatric Population
  • 4.2.2. Increasing Number of Surgical Procedures
  • 4.2.3. Increasing Prevalence of Cancer & Musculoskeletal Diseases
  • 4.2.4 Technological Advancements in Pain Management Devices
  • 4.2.5. Increasing Healthcare Expenditures
  • 4.2.6. Rising Number of Accidents & Sports Injuries
• 4.3. Restraints
  • 4.3.1. High Costs of Pain Management Devices & Therapies
  • 4.3.2. Product Recalls
• 4.4. Opportunities
  • 4.4.1. Partnerships & Collaborations by Pain Management Device Companies
  • 4.4.2. Integration of Digital Health Technologies into Pain Management Devices
  • 4.4.3. Emerging Economies
• 4.5. Challenges
  • 4.5.1. Lack of Awareness Regarding the Use of Pain Management Devices in Developing Countries
  • 4.5.2. Use of Alternative Technologies
• 4.6. Trends
  • 4.6.1. Electrical Stimulation Devices
  • 4.6.2. Wearable Pain Management Devices
• 4.7. Factor Analysis
• 4.8. Regulatory Analysis
• 4.9. Pricing Analysis
• 4.10. Case Studies
• 4.11. Porter's Five Forces Analysis

5. Pain Management Devices Market Assessment-by Product

• 5.1. Overview
• 5.2. Neurostimulation Devices
  • 5.2.1. Deep Brain Stimulation (DBS) Systems
  • 5.2.2. Spinal Cord Stimulation Systems
  • 5.2.3. Transcutaneous Electrical Nerve Stimulation (TENS) Systems
  • 5.2.4. Vagus Nerve Stimulation (VNS) Systems
  • 5.2.5. Other Neurostimulation Devices
• 5.3. Analgesic Infusion Pumps
  • 5.3.1. Intrathecal Infusion Pumps
  • 5.3.2. External Infusion Pumps
• 5.4. Compression Therapy Devices
  • 5.4.1. Bandages
  • 5.4.2. Garments
    • 5.4.2.1. Stockings
    • 5.4.2.2. Socks & Sleeves
    • 5.4.2.3. Wraps & Tapes
    • 5.4.2.4. Other Garments
  • 5.4.3. Intermittent/Sequential Pneumatic Compression Pumps
  • 5.4.4. Other Pressure Pumps
• 5.5. Electrotherapy Devices
• 5.6. Ablation Devices
• 5.7. Accessories

6. Pain Management Devices Market Assessment-by Portability

• 6.1. Overview
• 6.2. Stationary/Benchtop
• 6.3. Wearable & Implantable

7. Pain Management Devices Market Assessment-by Pain Type

• 7.1. Overview
• 7.2. Acute Pain
  • 7.2.1. Injuries
  • 7.2.2. Surgeries
• 7.3. Chronic Pain
  • 7.3.1. Musculoskeletal Pain
  • 7.3.2. Neuropathic Pain
  • 7.3.3. Cancer Pain
  • 7.3.4. Other Chronic Pain Types

8. Pain Management Devices Market Assessment-by Distribution Channel

• 8.1. Overview
• 8.2. Hospital Pharmacies
• 8.3. Retail Pharmacies
• 8.4. Online/E-commerce Platforms

9. Pain Management Devices Market Assessment-by End User

• 9.1. Overview
• 9.2. Hospitals & Clinics
• 9.3. Ambulatory Surgical Centers
• 9.4. Physiotherapy Centers
• 9.5. Home Care Settings
• 9.6. Other End Users

10. Pain Management Devices Market Assessment-by Geography

• 10.1. Overview
• 10.2. North America
  • 10.2.1. U.S.
  • 10.2.2. Canada
• 10.3. Europe
  • 10.3.1. Germany
  • 10.3.2. France
  • 10.3.3. U.K.
  • 10.3.4. Italy
  • 10.3.5. Spain
  • 10.3.6. Switzerland
  • 10.3.7. Rest of Europe
• 10.4. Asia-Pacific
  • 10.4.1. Japan
  • 10.4.2. China
  • 10.4.3. India
  • 10.4.4. Australia
  • 10.4.5. South Korea
  • 10.4.6. Rest of Asia-Pacific
• 10.5. Latin America
  • 10.5.1. Brazil
  • 10.5.2. Mexico
  • 10.5.3. Rest of Latin America
• 10.6. Middle East & Africa

11. Competition Analysis

• 11.1. Overview
• 11.2. Key Growth Strategies of Leading Market Players
• 11.3. Competitive Benchmarking
• 11.4. Competitive Dashboard
  • 11.4.1. Industry Leaders
  • 11.4.2. Market Differentiators
  • 11.4.3. Vanguards
  • 11.4.4. Emerging Companies
• 11.5. Market Share Analysis/Market Rankings of Key Players (2023)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 12.1. Abbott Laboratories
• 12.2. Becton, Dickinson and Company
• 12.3. Boston Scientific Corporation
• 12.4. Johnson & Johnson Services, Inc.
• 12.5. Baxter International, Inc.
• 12.6. VirpaxPharmaceuticals, Inc.
• 12.7. B. Braun Melsungen AG
• 12.8. Medtronic plc
• 12.9. Rusan Pharma Ltd
• 12.10. Grunenthal GmbH
• 12.11. OMRON Healthcare, Inc.
• 12.12. Nevro Corp.

(Note: SWOT analysis will be provided for the top 5 companies.)

13. Appendix

• 13.1. Available Customization
• 13.2. Related Reports